NYSE: ABBVAbbVie Inc Earnings & Revenue
ABBV past earnings growth
How has ABBV's earnings growth performed historically?
Company
67.97%
Industry
10.68%
Market
82.89%
ABBV's earnings have grown faster (29.42% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
ABBV's earnings have grown slower (29.42% per year) than the US market average (77.34%)
Performance
ABBV's earnings growth is accelerating - its growth over the last year (67.97%) is above its 5-year compound annual rate (29.42%)
Performance
ABBV past revenue growth
How has ABBV's revenue growth performed historically?
Company
11.04%
Industry
6.62%
Market
16.55%
ABBV's revenue has grown faster (11.54% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
ABBV's revenue has grown slower (11.54% per year) than the US market average (15.67%)
Performance
ABBV's revenue growth is slowing down - its growth over the last year (11.04%) is below its 5-year compound annual rate (11.54%)
Performance
ABBV earnings and revenue history
Current Revenue
$36.2B
Current Earnings
$7.0B
Current Profit Margin
19.2%
ABBV Return on equity
Current Company
-305.6%
Current Industry
10.9%
Current Market
-36.3%
ABBV's Return on Equity (-305.6%) shows a company that is not efficient at transforming shareholder equity into returns
Performance
ABBV Return on assets
Current Company
7.1%
Current Industry
8.5%
Current Market
6.2%
ABBV is generating lower Return on Assets (7.1%) than the US Drug Manufacturers - General industry average (8.27%)
Performance
ABBV Return on capital employed
Current Company
7.53%
Current Industry
12.8%
ABBV's ability to generate Return on Capital (7.53%) has decreased compared to 3 years ago (17.34%)
Performance
ABBV earnings dates
- Next earnings date
- Oct 30, 2020
AbbVie Earnings & Revenue FAQ
What were ABBV's earnings last quarter?
On May 01, 2020, AbbVie (NYSE: ABBV) reported Q1 2020 earnings per share (EPS) of $2.02, up 22.42% year over year. Total AbbVie earnings for the quarter were $3.01 billion. In the same quarter last year, AbbVie's earnings per share (EPS) was $1.65.
What was ABBV's revenue last quarter?
On May 01, 2020, AbbVie (NYSE: ABBV) reported Q1 2020 revenue of $8.62 billion up 10.1% year over year. In the same quarter last year, AbbVie's revenue was $7.83 billion.
What was ABBV's earnings growth in the past year?
As of Q4 2020, AbbVie's earnings has grown 67.97% year over year. This is 57.29 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. AbbVie's earnings in the past year totalled $6.96 billion.
What was ABBV's revenue growth in the past year?
As of Q4 2020, AbbVie's revenue has grown 11.04% year over year. This is 4.43 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. AbbVie's revenue in the past year totalled $36.23 billion.
What is ABBV's earnings date?
AbbVie's earnings date is Oct 30, 2020. Add ABBV to your watchlist to be reminded of ABBV's next earnings announcement.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
